Deanna L. Kirkpatrick
Lawyers
Filters
VF $3 billion senior notes offering
Davis Polk advised VF Corporation in connection with an SEC-registered debt shelf takedown of $1 billion aggregate principal amount of its 2.050% senior notes due 2022, $750 million…
DXC Technology $1 billion senior notes offering
Davis Polk advised the representatives of the several underwriters in connection with the registered offering by DXC Technology Company of $500 million aggregate principal amount of 4.000%…
Shake Shack $140 million common stock offering
Davis Polk advised the representative of the several underwriters in connection with the public offering of $140 million of Class A common stock of Shake Shack Inc. Shake Shack is listed on…
Shake Shack $75 million at-the-market offering
Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by Shake Shack Inc. of shares of its Class A common stock for up to a maximum offering…
Kala Pharmaceuticals $126.2 million stock offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering of 16,000,000 shares of common stock…
GFL Environmental $2.2 billion dual-listed U.S. and Canadian IPO
Davis Polk advised the underwriters, in connection with a $2.2 billion dual-listed U.S. and Canadian initial public offering of 75,000,000 subordinate voting shares ($1.425 billion)…
Millendo Therapeutics amendments of at-the-market offering program
Davis Polk advised the sales agents in connection with certain amendments of the SEC-registered at-the-market offering program by Millendo Therapeutics, Inc. of up to $50 million gross…
VF €1 billion senior notes offering, including €500 million in green bonds
Davis Polk advised VF Corporation in connection with an SEC-registered debt shelf takedown of €500 million aggregate principal amount of its 0.250% senior notes due 2028 (the “2028 notes”)…
BioXcel Therapeutics $73.6 million stock offering
Davis Polk advised the underwriters in connection with the SEC-registered offering by BioXcel Therapeutics, Inc. of 2,300,000 shares of its common stock. The common stock is listed on the…
Export Development Canada $2 billion global bond offering
Davis Polk advised the underwriters in connection with the offering of $2 billion aggregate principal amount of 1.375% U.S. dollar bonds due 2023 issued by Export Development Canada.
Export…